Roland Schmieder
Latest contributions
Interventions for hypertension: latest developments
20 May 2026 – From EuroPCR 2026
This session reviews the latest developments in interventional treatments for hypertension, focusing on renal denervation (RDN) technologies and clinical outcomes. It includes comparative procedural data from global registries and studies, novel computational assessments, and applications in specific patient populations such as those with polycystic kidney disease...
Renal interventions
15 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on renal interventions. It will cover various topics, including a novel approach to handle renal artery stenoses, an interesting case of paroxysmal nocturnal dyspnoea, accessory arteries in renal denervation and OCT, as well as renal denervation...
The turning point in hypertension care: Symplicity Spyral renal denervation in practice
15 May 2024 – From EuroPCR 2024
Explore this session to grasp the FDA-approved status of renal denervation, its safety and efficacy shown in numerous studies with lasting effects, and the importance of multidisciplinary discussions for successful indications. Consult also the session for updated recommendations on renal denervation in hypertension treatment guidelines, procedural safety...
Intervention around arterial hypertension
18 May 2023 – From EuroPCR 2023
Explore the realm of interventions in the context of arterial hypertension in this session: witness the remote haemodynamic monitoring of heritable pulmonary arterial hypertension, uncover the case of unilateral renal atrophy four years after renal sympathetic denervation, break the "boundaries" posed by calcification in renovascular hypertension,...
